These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37690088)

  • 1. A New Dawn for Aldosterone as a Therapeutic Target in Hypertension.
    Williams B
    JAMA; 2023 Sep; 330(12):1138-1139. PubMed ID: 37690088
    [No Abstract]   [Full Text] [Related]  

  • 2. Reviving the use of aldosterone inhibitors in treating hypertension in obesity.
    Huby AC; Belin De Chantemèle EJ
    Am J Physiol Regul Integr Comp Physiol; 2015 Nov; 309(9):R1065-7. PubMed ID: 26157057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drug targets for hypertension: A literature review.
    Gao Q; Xu L; Cai J
    Biochim Biophys Acta Mol Basis Dis; 2021 Mar; 1867(3):166037. PubMed ID: 33309796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aldosterone blockade in essential hypertension].
    Venco A; Grandi AM
    Ital Heart J; 2005 May; 6 Suppl 1():34S-42S. PubMed ID: 15945298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Implementation of Aldosterone-Targeted Therapy in Patients With Hypertension.
    Pitt B; Vaidya A
    Circulation; 2023 Mar; 147(13):991-992. PubMed ID: 36972341
    [No Abstract]   [Full Text] [Related]  

  • 7. Aldosterone antagonists in hypertension and heart failure.
    Mantero F; Lucarelli G
    Ann Endocrinol (Paris); 2000 Feb; 61(1):52-60. PubMed ID: 10790593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MicroRNA and hypertension].
    Duan L; Xiong XJ; Wang J
    Zhongguo Zhong Yao Za Zhi; 2014 Feb; 39(3):397-401. PubMed ID: 24946537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of aldosterone in resistant hypertension: implications for pathogenesis and therapy.
    Epstein M; Calhoun DA
    Curr Hypertens Rep; 2007 Apr; 9(2):98-105. PubMed ID: 17442219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin and aldosterone measurements in the diagnosis and management of hypertension. II. Renin and aldosterone measurements as guide of drug therapy in hypertension.
    Hsieh BS; Chen WY; Yen TS
    Taiwan Yi Xue Hui Za Zhi; 1977 Dec; 76(12):906-15. PubMed ID: 273653
    [No Abstract]   [Full Text] [Related]  

  • 11. Aldosterone receptor antagonists for hypertension: what do they offer?
    Liew D; Krum H
    Drugs; 2003; 63(19):1963-72. PubMed ID: 12962513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renin-aldosterone and bone metabolism].
    Ikeda K
    Clin Calcium; 2014 Jun; 24(6):885-91. PubMed ID: 24870840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive therapy: role of aldosterone antagonists.
    Grandi AM
    Curr Pharm Des; 2005; 11(17):2235-42. PubMed ID: 16026292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension.
    Gaddam KK; Pratt-Ubunama MN; Calhoun DA
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):353-9. PubMed ID: 16716096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Prevalence of Autonomous Aldosterone Production in Hypertension: How to Identify and Treat It.
    Wannachalee T; Lieberman L; Turcu AF
    Curr Hypertens Rep; 2022 May; 24(5):123-132. PubMed ID: 35165831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone and refractory hypertension: a prospective cohort study.
    Sartori M; Calò LA; Mascagna V; Realdi A; Macchini L; Ciccariello L; De Toni R; Cattelan F; Pessina AC; Semplicini A
    Am J Hypertens; 2006 Apr; 19(4):373-9; discussion 380. PubMed ID: 16580572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone synthase inhibition in hypertension.
    Andersen K
    Curr Hypertens Rep; 2013 Oct; 15(5):484-8. PubMed ID: 23917810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of aldosterone synthase inhibition as an add-on therapy in resistant hypertension.
    Karns AD; Bral JM; Hartman D; Peppard T; Schumacher C
    J Clin Hypertens (Greenwich); 2013 Mar; 15(3):186-92. PubMed ID: 23458591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone target organ protection by eplerenone.
    Rudolph AE; Rocha R; McMahon EG
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):229-38. PubMed ID: 15134822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
    Schumacher CD; Steele RE; Brunner HR
    J Hypertens; 2013 Oct; 31(10):2085-93. PubMed ID: 24107737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.